The largest database of trusted experimental protocols

Ivis 2000 system

Manufactured by PerkinElmer
Sourced in United States

The IVIS 2000 system is a high-performance in vivo imaging platform designed for preclinical research. It enables non-invasive, real-time visualization and quantification of biological processes in living subjects. The system provides advanced optical imaging capabilities, including bioluminescence and fluorescence imaging.

Automatically generated - may contain errors

2 protocols using ivis 2000 system

1

Orthotopic Liver Tumor Implantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal experiments were performed in accordance with the laws and regulations governing animal experiments in the Federal Republic of Germany, following the approval of the respective animals’ ethics committee (Regierungspräsidium Karlsruhe, Germany). Initially, eight animals (6 weeks-old) weighing 120-130 g were bought from Charles River Company (Sulzfeld, Germany). The rats were maintained in ventilated macrolon cages, under controlled conditions (22°C ± 1°C temperature, 55% humidity and 12h dark/light rhythm) in a specific pathogen free animal facility at the German Cancer Research Center (DKFZ). They were allowed unlimited access to a commercial chow and autoclaved tap water ad libitum. Prior to the commencement of any experiment, a seven day window was adhered to, for acclimatization. For tumor implantation, the abdominal cavity was opened under anesthesia (Isoflurane) and ∼3 × 106 cells/animal were injected intraportally (via a mesocolic vein) under the microscope. Wounds were closed by suturing the musculature followed by attaching the edges of the separated skins by surgical wound clips. Tumor growth was monitored on a weekly basis by subcutaneous injection of luciferin (500μl/animal), prior to imaging by IVIS 2000 system (Perkin Elmer, US).
+ Open protocol
+ Expand
2

Orthotopic Xenograft of HD-MB03 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the orthotopic xenograft study, immunocompromised NOD-scid IL2Rgammanull (or NSG) mice, 6–8 weeks old, were purchased from Jackson Laboratory. HD-MB03 cells expressing RFP/luciferase (2.5 × 105) were suspended in 3 μl neural stem cell media and injected into cerebella (2 mm posterior to the lambda suture, 2 mm lateral to the midline, and 2.5 mm deep) of mice brain using Hamilton neurosyringe (33G) attached to the stereotaxic apparatus (David Kopf Instruments). Mice bearing HD-MB03/Luciferase xenografts were detected by bioluminescence imaging, performed at 5 days after intracranial implantation. Mice with a detectable signal were divided into four groups (n=5): vehicle (DMSO), cisplatin (2 mg/kg), CBL0137 (50 mg/kg), and combination of both cisplatin plus CBL0137, and treatments were given intraperitoneally every four days for 16 days. Mice were imaged on the IVIS2000 system (Perkin-Elmer) at day 5 and at day 21 after injecting with D-luciferin (70 mg/kg). Mice from each group were sacrificed on day 21 and their brains were harvested. H&E staining and IHC analyses of Ki67 were performed to confirm the histology and proliferating tumor cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!